Home > Common Disease Medicines > Pharmaceutical Tablets
Dilminox Tablets
mark as favourite

Dilminox Tablets

Get Latest Price
Description Minoxidil (Dilminox) is an orally active peripheral vasodilator. The pure compound is soluble in water to the extent of approximately 2 mg/ml and is readily soluble in propylene glycol or ethanol. Chemically, Minoxidil (Dilminox) is 2.4-diamino-6-piperidino-pyrimidine-3-oxide. The Molecular Weight is 209.25. Composition Each uncoated tablet of Dilminox contains Minoxidil I.P. 5 mg Pharmacology Minoxidil
Contact SellerAsk for best deal
Get Latest PriceRequest a quote
Share via

Steadfast MediShield Pvt. Ltd

Sector 4, Noida, Uttar Pradesh
View Mobile Number
Call +91-8826393544
Verified Supplier
Wholesale Trader
Ask for more details from the seller
Contact Seller

Product Details

Product Description

Description

Minoxidil (Dilminox) is an orally active peripheral vasodilator. The pure compound is soluble in water to the extent of approximately 2 mg/ml and is readily soluble in propylene glycol or ethanol. Chemically, Minoxidil (Dilminox) is 2.4-diamino-6-piperidino-pyrimidine-3-oxide. The Molecular Weight is 209.25.

Composition

Each uncoated tablet of Dilminox contains Minoxidil I.P. 5 mg

Pharmacology

Minoxidil (Dilminox) selectively relaxes the arteriolar smooth muscle, which reduces peripheral vascular resistance and lowers systemic blood pressure. This is accomplished without a diminution of nutritional flow to body tissues or interference with normal vasomotor reflexes.

Minoxidil (Dilminox) does not directly stimulate the heart or electrolyte reabsorption of the kidney. However, Minoxidil’s (Dilminox) administration elicits a reflex mediated increase in cardiac output, salt and water retention, and a rise in plasma renin activity. These effects are diminished by the simultaneous administration of diuretics and beta-adrenergic blocking agents.

Gastrointestinal absorption is rapid and amounts to at least 95% of the administered dose. Serum levels of the parent drug peak within the first hour. The plasma elimination half-life of Minoxidil (Dilminox) is approximately 4-4.5 hours, but the duration of its hypotensive action may exceed 24 hours. This disparity between blood level and pharmacological effect and the large volume of distribution indicated extensive tissue localization of the drug. However, on chronic treatment, accumulation does not occur and the pharmacological effect is slowly reversible.

With an effective oral dose, blood pressure usually starts to decline within one — half hour, reaches a minimum between 2 and 3 hours and recovers at a rate of approximately 30%/day.

During daily administration, there is a cumulative effect which reaches a steady state after 3 to 7 days. The magnitude of the blood pressure response is related to the extent of the original diastolic elevation above 85 mm Hg and is proportional to the logarithmic function of the dose administered. When the desired diastolic reduction is greater than 30 mm Hg, twice a day dosing is advised to keep the diurnal variation within 10 mm Hg.

Minoxidil does not bind to plasma proteins, enter the central nervous system or accumulate in body tissues. Metabolism is predominantly by glucuronic acid conjugation. Metabolites are excreted principally in the urine and can be removed by hemodialysis in anephric patients. Hemodialysis does not, however, rapidly reverse the pharmacological effect of Minoxidil.

Indications

It is indicated as adjunctive therapy in adults with severe refractory hypertension, which has failed to respond to extensive multiple therapies. When used in combination with an accompanying diuretic and beta-blocker, Minoxidil (Dilminox) has been shown to reverse encephalopathy and retinopathy in severe hypertensives.

Contraindications

Minoxidil (Dilminox) is contraindicated in phaeochromocytoma and pulmonary hypertension secondary to mitral stenosis.

Warnings

If used alone, Minoxidil (Dilminox) can cause a significant retention of salt and water, producing dependent oedema, puffiness of face, eyes or hands, neck vein distention and hepatojugular reflux. Chest X-rays may show evidence of pulmonary vascular engagement.

 


Product Image

Dilminox Tablets

Company Details


About the Company

Legal Status of FirmPrivate Limited Company
Nature of BusinessWholesale Trader
IndiaMART Member SinceJun 2016
Send your enquiry to this supplier
I agree to the terms and privacy policy

Seller Contact Details

Tell us what you
need
Receive seller
details
Seal the deal
Save time! Get Best Deal
I agree to the terms and privacy policy



X
I agree to the terms and privacy policy
Get Best Price
Hi
I agree to the terms and privacy policy

Have a requirement?
Get Best Price1